|
|
|
01 Apr 2008 |
SPP100 (Tekturna/Rasilez) reduces left ventricular hypertrophy
|
|
01 Apr 2008 |
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
|
|
01 Apr 2008 |
Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
|
|
01 Apr 2008 |
Amorcyte Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction
|
|
01 Apr 2008 |
Merck's Investigational Rolofylline Associated with Improved Dyspnea and Preserved Renal Function in Acute Heart Failure Patients in a Phase III Pilot Study
|
|
31 Mar 2008 |
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
|
|
31 Mar 2008 |
Crestor Outcomes Study JUPITER Closes Early Due To Unequivocal Evidence Of Benefit
|
|
31 Mar 2008 |
Rasilez(R) , the first-in-class direct renin inhibitor, reduces left ventricular hypertrophy, a powerful predictor of heart disease
|
|
31 Mar 2008 |
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients with Type 2 Diabetes
|
|
31 Mar 2008 |
Cytokinetics Announces Presentation of Non-clinical Data Relating to CK-1827452 at the 2008 Annual Scientific Sessions of The American College of Cardiology
|
|
30 Mar 2008 |
Merck/Schering-Plough Pharmaceuticals Comments on Results of the ENHANCE Study
|
|
27 Mar 2008 |
Novel oral anticoagulant Pradaxa(R) (dabigatran etexilate) approved by the European Commission
|
|
27 Mar 2008 |
OMRIX Biopharmaceuticals Initiates Phase II Clinical Trial for Fibrin Patch Product Candidate
|
|
24 Mar 2008 |
Cytokinetics Announces Positive Results from an Interim Analysis of an Ongoing Phase IIA Clinical trial of CK-1827452 in Patients with Stable Heart Failure
|
|
20 Mar 2008 |
Pharming To Receive Negative Opinion On European Marketing Authorization Application For Rhucin(R)
|
|
20 Mar 2008 |
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
|
|
18 Mar 2008 |
Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155 at SIR Annual Scientific Meeting
|
|
17 Mar 2008 |
Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
|
|
17 Mar 2008 |
OMRIX Biopharmaceuticals Provides Update on its Fibrin Patch Product Candidate
|
|
17 Mar 2008 |
Archemix Announces Initiation of Phase 2 Trial for Aptamer Product Candidate ARC1779 in Patients with TTP, a Rare, Life-Threatening Blood Disorder
|
|
17 Mar 2008 |
Takeda Submitted a New Drug Application for a Fixed Dose Combination Tablet of Blopress(R) with Diuretic in Japan for Treatment of Hypertension
|
|
17 Mar 2008 |
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
|
|
12 Mar 2008 |
Luitpold Pharmaceutical’s INJECTAFER™ (ferric carboxymaltose injection) receives non-approvable letter from FDA
|
|
12 Mar 2008 |
Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
|
|
11 Mar 2008 |
Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
|
|
10 Mar 2008 |
Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
|
|
10 Mar 2008 |
Palatin Technologies, Inc. Reports positive results of a Phase I clinical study with PL-3994 for the treatment of congestive heart failure
|
|
07 Mar 2008 |
THE LANCET publishes phase IIa study results with Cytos Biotechnology’s hypertension vaccine CYT006-AngQb
|
|
06 Mar 2008 |
CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
|
|
05 Mar 2008 |
Biovitrum and Syntonix set to begin phase I/IIa clinical trial of long-acting recombinant Factor IXFc for the treatment of Hemophilia B
|
|
05 Mar 2008 |
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
|
|
04 Mar 2008 |
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
|
|
03 Mar 2008 |
FDA grants Priority Review For Promacta / Revolade (Eltrombopag)
|
|
29 Feb 2008 |
Actelion and Nippon Shinyaku to collaborate on novel PAH compound
|
|
28 Feb 2008 |
PAION's anticoagulant Solulin successfully tested in first-in-man study
|
|
26 Feb 2008 |
Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack
|
|
26 Feb 2008 |
Pharmacopeia Completes Enrolment in Phase 2 Hypertension Study with PS433540 (DARA)
|
|
25 Feb 2008 |
Harvest Technologies announces patient enrollment has begun for a clinical trial in India using autologous adult stem cells to treat patients with non-reconstructible Critical Limb Ischemia (CLI) due to Peripheral Arterial Occlusive Disease (PAOD)
|
|
25 Feb 2008 |
Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
|
|
22 Feb 2008 |
Artisan Pharma's Lead Product, ART-123, Approved in Japan
|
|
21 Feb 2008 |
Daiichi Sankyo, Lilly Submit Marketing Authorization Application for Investigational Oral Antiplatelet Drug; Prasugrel, to European Medicine Agency
|
|
21 Feb 2008 |
FDA grants priority review for Daiichi Sankyo, Lilly drug, prasugrel Investigational antiplatelet agent submitted for treatment of patients with acute coronary syndrome being managed with percutaneous coronary intervention
|
|
21 Feb 2008 |
Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
|
|
14 Feb 2008 |
Biogen Idec and Cardiokine Initiate Phase III Clinical Trial for Lixivaptan in Congestive Heart Failure Patients with Hyponatremia
|
|
13 Feb 2008 |
Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint
|
|
12 Feb 2008 |
Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR for Potential Treatment of Cardiovascular Pathologies
|
|
12 Feb 2008 |
Altor BioScience In-Licenses Tissue Factor Antagonists from Genentech
|
|
07 Feb 2008 |
Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
|
|
06 Feb 2008 |
Biovitrum and Symphogen have Successfully Completed Phase I Clinical Trial with Recombinant Polyclonal Antibody
|
|
06 Feb 2008 |
Neose Receives Milestone Payment from Novo Nordisk on Factor VIII Program
|
| |
|
Results 251 - 300 of 1042 |
